VCAM1 and COVID-19: Hence, the aim of our study was to evaluate and compare the profiles of endocan and other endothelial dysfunction biomarkers (ICAM-1, VCAM-1 and E-selectin) in hospitalized patients with different stages of COVID-19 severity, including critical COVID-19 on VV-ECMO patients.